Company Search:
Advanced Search
Sponsored Links
Genetics Generation Advancement Corp Company Snapshot
Genetics Generation Advancement Corp operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genetics Generation Advancement Corp with three other pharmaceutical manufacturers in Asia: Biotoxtech Company Limited of KOREA (SOUTH) (2020 sales of 26.43 billion Korean Won [US$23.63 million] ), CellSource Co Ltd of JAPAN (1.86 billion Japanese Yen [US$16.85 million] of which 91% was Regenerative Medicine Related Business), and Suzhou Basecare Medical Corp Ltd which is based in HONG KONG (91.37 million Hong Kong Dollars [US$11.77 million] ).

Sales Analysis. During the first quarter of 2021, sales at Genetics Generation Advancement Corp totalled 120.21 million Taiwanese Dollars . This is an increase of 13.5% from the 105.95 million Taiwanese Dollars in sales at the company during the first quarter of 2020. Genetics Generation Advancement Corp reported sales of 443.13 million Taiwanese Dollars (US$16.02 million) for the year ending December of 2020. This represents an increase of 3.2% versus 2019, when the company's sales were 429.38 million Taiwanese Dollars . Sales at Genetics Generation Advancement Corp have increased during each of the previous five years (and since 2015, sales have increased a total of 61%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Genetics Generation Advancement Corp
  Stock Performance Chart for Genetics Generation Advancement Corp
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 24.35
(Figures in Taiwanese Dollars )
1 Week -2.2%   13 Weeks 2.5%  
4 Weeks -1.6%   52 Weeks -17.3%  
Genetics Generation Advancement Corp Key Data:
  Ticker: 4160 Country: Taiwan
  Exchanges: TAI Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2020 Sales 443,130,000
(Year Ending Jan 2021).
Employees: 149
  Currency: Taiwanese Dollars Market Cap: 590,414,450
  Fiscal Yr Ends: December Shares Outstanding: 24,247,000
  Share Type: GU Closely Held Shares: 11,559,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.